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Successful containment of infection is dependent on both innate
and adaptive immune responses. Cytokines are essential compo-
nents of both of these systems. In particular, type I interferons
(IFN-I) are important components of early innate immunity
against infections. However, the production of IFN-I could serve
as a double-edged sword, in that it could help eliminate infections
or in certain instances enhance host’s susceptibility to infections.
For example, IFN-I provide early resistance against acute viral
infections, but are detrimental to the host during certain bac-
terial infections and chronic viral infections. This Research Topic
presents seven articles that address the biological roles of IFN-Is in
host immunity and various contexts (e.g., autoimmunity, cancer,
viral/bacterial infections, IFN-I therapy, etc.) where IFN-Is could
either serve to control or exacerbate disease.
The original research performed by Babb et al. investigates
the potential adjuvant activity of gamma-irradiated influenza (1).
They demonstrate that co-vaccination with gamma-irradiated-
influenza virus and poorly immunogenic inactivated Semliki
forest virus (SFV) results in enhanced SFV-specific antibody
responses without compromising humoral immunity against
influenza infections. They have previously shown that gamma-
irradiation destroys the ability of SFV but not influenza A virus
to elicit strong IFN-I responses (2). Thus, it is likely that the adju-
vant activity of gamma-irradiated influenza virus is attributable
to its potency of IFN-I induction. These authors speculate that
gamma-irradiated influenza virus may therefore be exploited as an
adjuvant to improve the efficacy of poorly immunogenic vaccines
owing to its ability to stimulate IFN-I production.
The potent immune activating properties of IFN-I can also
be detrimental during viral infection, particularly for viruses that
establish chronic infection. This certainly is the case for human
or simian immunodeficiency virus (HIV/SIV) infection in non-
natural hosts. As discussed by Tomasello et al. (3) and Furuya
et al. (4), IFN-I induced during HIV infections may play a path-
ogenic role in driving chronic immune activation associated with
CD4+ T cell depletion and loss of T cell function. Indeed, a strong
correlation exists between chronic low level productions of IFN-I
and disease progression in non-natural hosts. Thus, Furuya et al.
hypothesize that regulatory mechanisms must exist in natural
hosts that actively suppress IFN-I responses despite viral repli-
cation (4). It is speculated that understanding how the host can
co-exist with HIV without generating an IFN-I response will be
crucial in developing therapeutic interventions that can prevent or
dampen progression to an acquired immune deficiency syndrome
(AIDS). Perhaps, as pointed out by Tomasello et al., the more
important question that needs to be addressed first is whether a
causal link exists between low levels of IFN-I signaling and the
development of AIDS in non-natural hosts or, rather, the up-
regulation of IFN-stimulated genes simply a marker of disease
progression.
The pathogenic role of IFN-I is more widely observed in bacter-
ial infections. For example, the facultative intracellular bacterium
Francisella tularensis is less virulent in mice deficient in IFN-I
receptors (5, 6). Furuya et al. propose in an opinion article that
the detrimental role of IFN-I during pulmonary tularemia may
be linked to its suppressive effects on neutrophil recruitment,
a response that may be protective against respiratory Francisella
tularensis infection (7). The role of neutrophils during pulmonary
tularemia has yet to be fully defined, but it is likely that both
the magnitude and timing of cellular recruitment to the lung
will determine whether neutrophils promote bacterial clearance
or contribute to immunopathology.
In three review articles, the mechanisms that have been pro-
posed to explain the IFN-I-mediated increases in bacterial infec-
tion susceptibility are discussed. The review article by Eshleman
et al. focuses on the suppressive effects of IFN-I on myeloid
cells during intracellular bacterial infections (8). These authors
also emphasize that IFN-I can exert a positive anti-inflammatory
effect in a number of autoimmune diseases and that this is medi-
ated by the suppression of myeloid cell inflammatory responses.
The review article from Dhariwala et al. describes multiple path-
ways of IFN-I-dependent cell deaths that may aid bacteria escape
phagocytosis and thereby contributes to bacterial pathogenesis
(9). Indeed, as the author pointed out, bacterial pathogens that
benefits from IFN-I signaling are often facultative intracellular
bacteria. The final review by Wijesundara et al. highlights patho-
logical contexts in which IFN-I could be exploited in therapy and
vaccine design with a particular emphasis on IFN-epsilon (10).
IFN-epsilon appears to have both overlapping and distinct func-
tions compared to IFN-alpha and -beta, and therefore, the author
urge the need of evaluating contribution of the different members
of IFN-I to fully exploit its beneficial effects.
Despite IFN-I being perhaps the most studied cytokine, their
immunoregulatory roles are not fully understood. As is evident
from the articles presented in this Research Topic, the role played
by IFN-I is highly context-dependent and can be both beneficial
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and detrimental. Further research is clearly required in order for us
to selectively harness the protective role of IFN-I while suppressing
its damaging effects.
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